Arcturus Therapeutics Holdings Inc.
ARCTNasdaqCIK 1768224HealthcareFiscal year ends Dec 31
Reports and events: 143 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-07-1407:53 ET | 8-K | 7.01 Regulation FD disclosure | 0001193805-23-000984 |
| 2023-06-3008:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-23-000929 |
| 2023-06-1616:32 ET | 8-K | 5.07 Shareholder vote results | 0001193805-23-000861 |
| 2023-05-0916:36 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-019773 |
| 2023-05-0916:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-23-000686 |
| 2023-05-0116:32 ET | DEF 14A | Proxy statementPeriod 2023-06-14 | 0001193805-23-000633 |
| 2023-04-2806:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-23-000619 |
| 2023-04-2117:21 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193805-23-000595 |
| 2023-04-1109:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-23-000532 |
| 2023-03-2918:33 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-010380 |
| 2023-03-2816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-23-000401 |
| 2023-03-1716:15 ET | 8-K | 1.02 Termination of a material agreement | 0001193805-23-000356 |
| 2022-12-1316:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-22-001719 |
| 2022-12-1308:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-22-001712 |
| 2022-11-0916:55 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-023969 |
| 2022-11-0916:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-22-001504 |
| 2022-11-0417:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193805-22-001480 |
| 2022-11-0218:36 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193805-22-001470 |
| 2022-09-0117:09 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193805-22-001230 |
| 2022-08-0916:08 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016043 |
| 2022-08-0916:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-22-001152 |
| 2022-06-2417:23 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193805-22-001014 |
| 2022-05-0916:31 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-008524 |
| 2022-05-0916:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-22-000752 |
| 2022-05-0217:20 ET | DEF 14A | Proxy statementPeriod 2022-06-21 | 0001193805-22-000731 |
| 2022-04-2017:24 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-22-000672 |
| 2022-03-0121:10 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001564590-22-007832 |
| 2022-02-2816:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-22-000402 |
| 2022-02-1707:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-22-000358 |
| 2022-02-1117:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193805-22-000265 |
| 2022-01-1107:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001193805-22-000036 |
| 2021-12-1317:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.05 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-21-001738 |
| 2021-11-1616:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-21-001584 |
| 2021-11-0919:10 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-055372 |
| 2021-11-0816:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-21-001541 |
| 2021-11-0116:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193805-21-001517 |
| 2021-10-0517:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193805-21-001417 |
| 2021-08-2616:15 ET | 8-K | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors | 0001193805-21-001224 |
| 2021-08-1017:39 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-042750 |
| 2021-08-0916:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-21-001134 |
| 2021-08-0416:15 ET | 8-K | 1.01 Entry into a material agreement | 0001193805-21-001100 |
| 2021-06-2216:31 ET | 8-K | 5.07 Shareholder vote results | 0001193805-21-000923 |
| 2021-05-1016:58 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-026113 |
| 2021-05-1016:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-21-000630 |
| 2021-04-3016:01 ET | DEF 14A | Proxy statementPeriod 2021-06-18 | 0001193805-21-000583 |
| 2021-04-2617:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193805-21-000538 |
| 2021-03-0116:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-21-000289 |
| 2021-03-0116:18 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-009872 |
| 2021-02-2217:00 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-21-000256 |
| 2021-02-0313:00 ET | 8-K | 2.03 New direct financial obligation | 0001193805-21-000122 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 14:45 ET. Listed shows no prices and gives no investment advice.